KATHERINE TALSON: Open Payments
NPI 1578054276 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,226 in 113 payments from 19 companies in 2025. Trend: 2023 $255 · 2024 $1,406 · 2025 $2,226
Food & beverage: $2,151Education: $75
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $346 |
| Janssen Biotech, Inc. | 9 | $237 |
| Organon LLC | 25 | $228 |
| UCB, Inc. | 7 | $192 |
| Incyte Corporation | 7 | $180 |
| Novartis Pharmaceuticals Corporation | 13 | $155 |
| Lilly USA, LLC | 6 | $149 |
| ABBVIE INC. | 7 | $149 |
| Regeneron Healthcare Solutions, Inc. | 5 | $120 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $86 |
Products named: DUPIXENT, TREMFYA, Bimzelx, OPZELURA, COSENTYX, TALTZ, SKYRIZI, CIBINQO.
Industry payments across MD — which companies pay providers there.
